Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Emerging Drugs|June 7, 2005
Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritisJasper J Haringman, Roos L Oostendorp, Paul P Tak
Cancer Treatment Reviews|November 7, 2008
The biological and clinical role of drug transporters at the intestinal barrierRoos L Oostendorp, Jos H Beijnen, Jan H M Schellens
Biomedical Chromatography : BMC|March 28, 2007
Determination of imatinib mesylate and its main metabolite (CGP74588) in human plasma and murine specimens by ion-pairing reversed-phase high-performance liquid chromatographyRoos L Oostendorp, Jos H Beijnen, Jan H M Schellens, et al.
Cancer Chemotherapy and Pharmacology|December 21, 2006
The effect of hydroxyurea on P-glycoprotein/BCRP-mediated transport and CYP3A metabolism of imatinib mesylateRoos L Oostendorp, Serena Marchetti, Jos H Beijnen, et al.
Investigational New Drugs|May 2, 2008
The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinibRoos L Oostendorp, Tessa Buckle, Jos H Beijnen, et al.
British Journal of Clinical Pharmacology|June 25, 2010
Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancerStijn L W Koolen, Roos L Oostendorp, Jos H Beijnen, et al.
Investigational New Drugs|April 15, 2010
Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in miceRoos L Oostendorp, T Buckle, G Lambert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Coadministration of ritonavir strongly enhances the apparent oral bioavailability of docetaxel in patients with solid tumorsRoos L Oostendorp, Alwin Huitema, Hilde Rosing, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 14, 2009
Organic anion-transporting polypeptide 1B1 mediates transport of Gimatecan and BNP1350 and can be inhibited by several classic ATP-binding cassette (ABC) B1 and/or ABCG2 inhibitorsRoos L Oostendorp, Evita van de Steeg, Cornelia M M van der Kruijssen, et al.
Molecular Cancer Therapeutics|December 20, 2007
In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2Serena Marchetti, Roos L Oostendorp, Dick Pluim, et al.
Pageof 1